San Diego, CA, United States of America

Brandon Selfridge

USPTO Granted Patents = 12 

Average Co-Inventor Count = 6.7

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
12 patents (USPTO):

Title: The Innovative Contributions of Brandon Selfridge

Introduction

Brandon Selfridge is a prominent inventor based in San Diego, CA, known for his significant contributions to the field of pharmaceutical sciences. With a total of 12 patents to his name, he has made remarkable strides in the development of compounds that target specific receptors in the human body.

Latest Patents

Among his latest patents are innovative methods for modulating the mas-related G-protein receptor X2 (MRGPR X2). These methods provide a means for treating conditions dependent on MRGPR X2 by administering effective amounts of specific compounds. The patents detail pharmaceutical compositions that include these compounds, which are designed to interact with MRGPR X2 or its orthologs, offering potential therapeutic benefits.

Career Highlights

Brandon Selfridge has established himself as a key figure in the pharmaceutical industry through his work at Escient Pharmaceuticals, Inc. His research focuses on the modulation of G-protein coupled receptors, which play a crucial role in various physiological processes. His innovative approaches have the potential to lead to new treatments for conditions that currently lack effective therapies.

Collaborations

Throughout his career, Brandon has collaborated with notable colleagues, including Marcus F Boehm and Liming Huang. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.

Conclusion

Brandon Selfridge's contributions to the field of pharmaceuticals through his patents and collaborative efforts highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…